The selected amplified ovarian cancer cells exhibited MECOM protein overexpression, and abrogating endogenous MECOM expression in these cells disrupted key cancer characteristics, including enhanced proliferation and migration. This evidence concerns the gene MECOM and ovarian carcinoma.